Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

This large, randomized Phase 3 clinical trial of high-dose coenzyme Q10 failed to show any neuroprotective benefit in early Parkinson’s disease.

No Evidence Supporting Coenzyme Q10 Use in Parkinson’s Disease